logo
Deanne thought her one-year-old daughter only had a cold. The reality was much much worse - and her little girl is still suffering agonising symptoms months later

Deanne thought her one-year-old daughter only had a cold. The reality was much much worse - and her little girl is still suffering agonising symptoms months later

Daily Mail​2 days ago

A mum has revealed the horrifying moment her six-week-old baby girl went limp and stopped breathing less than two days after catching a cold.
Adelaide nurse and mother-of-two Deanne Tingey thought her little girl, Winter, was suffering from a common cold in May last year.
The 27-year-old told Daily Mail Australia that her daughter's initial symptoms included a runny nose and a slight cough.
But as the day progressed, she started to go downhill.
Ms Tingey said Winter wasn't eating as much as usual and her cough had developed, prompting her to book an appointment with her doctor.
'By the time we got to the GP, which was 2pm the following day, Winter had not fed at all in the morning and only had one wet nappy,' Ms Tingey said.
'My GP told me to take her straight to the emergency department. So from his office we went to the hospital.'
Ms Tingey said by the time they arrived, Winter was struggling to breathe, drowsy, limp and gasping for air.
In less than 24 hours, Winter was fighting for her life and was taken directly to the Resus Bay - a dedicated space in hospital emergency departments designed to provide treatment for patients with critical or life-threatening conditions.
'They put her on high-flow oxygen and put a gastric tube in her straight away,' Ms Tingey said.
'They started giving her Panadol, taking bloods, swabbing her and said she had the classic signs of RSV.'
Doctors discovered Winter was suffering from respiratory syncytial virus (RSV) - a common illness that causes respiratory infections, especially in babies and young kids.
The virus can also lead to serious illnesses including bronchiolitis and pneumonia.
While most people experience mild, cold-like symptoms, RSV can be fatal for infants or cause serious complications and long-term respiratory problems into adulthood.
'I kind of felt like a failure, because being a nurse, I should have looked out for those signs,' Ms Tingey said.
'Just watching her struggle so badly, it was absolutely heartbreaking. It's actually one of the worst things that I've ever seen.'
Ms Tingey remembers the doctors explaining that the 'entire ward was full of babies with RSV'.
Doctors discharged Winter 24 hours after she had arrived at hospital - a decision Ms Tingey felt was wrong.
The concerned mother rushed her baby back to the hospital once more, just six hours after being discharged when she started to go blue and was very limp.
'I was hesitant to take her home, but I agreed to take her home because I had doctors telling me she'll be fine at home,' Ms Tingey said.
'As a nurse I felt annoyed at myself but when it's your own child you don't think about it in nursing terms. In that moment I was a mother, not a nurse.
'But there was a part of me that thought this is too early. I'm just glad that I took her back.'
Ms Tingey stayed in the hospital full-time with Winter for another week as she received treatment while her mum looked after her young son.
Winter developed bronchiolitis - a chest infection that affects the small airways in the lungs - as a result of the RSV.
She would also stop breathing during her sleep and had to wear an overnight sock that monitored her oxygen levels.
Now, Winter, aged one, suffers from a chronic cough, still stops breathing during her sleep, has difficulties swallowing and has a rattling sound in her chest.
She also has to drink thickened milk and thickened water to stop her from choking when she drinks as her airway kept collapsing when she had RSV.
Winter is set to have a surgery to secure her airway, known as a tracheoplasty, once she gains another two kilograms and reaches 10kg.
Ms Tingey described her little girl as an 'absolute firecracker' who is 'full of sass'.
The young mum said she wants to raise awareness of RSV and urged parents across the country to learn how to recognise the early signs.
'The amount of people that still don't even know what RSV is, blows my mind,' Ms Tingey said.
'Please know what the signs and symptoms are. Know that there's help available and get your child checked early if they start to sniffle or look like they're sick.'
She also urged parents to 'advocate' for their children and to trust their gut instincts when they feel something my not be right.
Cases of RSV are expected to surge as Australia heads into the cooler months, with RSV awareness week marked on the first week of winter from June 1 to 7.
RSV is the leading cause of lower respiratory tract infections in infants and result in more hospitalisations in infants and young children than influenza 1, 2, 3 and 4.
In Australia, infants under 12 months are more than 12 times as likely to be admitted to hospital with RSV than those aged between one and four years old.
Last year, more than 170,000 RSV cases were reported, with 50 per cent of those in infants and children aged between zero and four years old.
To date, more than 50,000 cases of RSV have been reported since the beginning of the year.
Babies with mild symptoms of RSV need small, regular amounts of fluid including breastmilk or infant formula.
A parent should call Triple Zero or got o a hospital emergency department immediately if their child is showing severe symptoms.
Severe symptoms include difficulty breathing, grunting noises while breathing, dehydration - when a child is not taking in enough fluids - and blue-coloured lips or skin.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New test for coeliac disease could increase diagnosis rates
New test for coeliac disease could increase diagnosis rates

The Independent

time2 hours ago

  • The Independent

New test for coeliac disease could increase diagnosis rates

A new blood test for gluten -specific T cells can detect coeliac disease even without gluten consumption, according to research published in Gastroenterology. The new blood test could increase diagnosis rates, identify those at risk of severe reactions, and detect silent coeliac disease. The test measures the immune marker interleukin 2 (IL-2), which spikes in the bloodstream of people with coeliac disease after gluten consumption. The study showed the test could detect coeliac disease with up to 90 per cent sensitivity and 97 per cent specificity, even in patients on a gluten -free diet. Researchers are collaborating with Novoviah Pharmaceuticals to confirm the test's accuracy across diverse populations and gather real-world data, potentially leading to faster and safer diagnoses. 'Game-changer' new blood test to detect prevalent autoimmune disease without nightmare side effects

It is the sunscreen brand singled out by CHOICE as the single WORST failure in Australian SPF 50+ tests. Now the skincare giant furiously hits back
It is the sunscreen brand singled out by CHOICE as the single WORST failure in Australian SPF 50+ tests. Now the skincare giant furiously hits back

Daily Mail​

time2 hours ago

  • Daily Mail​

It is the sunscreen brand singled out by CHOICE as the single WORST failure in Australian SPF 50+ tests. Now the skincare giant furiously hits back

One of the most popular sunscreen brands singled out by a consumer group for failing to meet Australia's strict SPF 50+ regulations has furiously hit back at the controversial experiment. But consumer group CHOICE has revealed it was 'so perturbed' by the results of its extraordinary first experiment - which found Ultra Violette's Lean Screen SPF50+ Mattifying Zinc Skinscreen returned an SPF of just 4 - that it conducted a second test at an independent lab in Germany. CHOICE found that 16 of 20 sunscreens tested in Australia failed to meet the SPF protection claims on its labels, including big brands such as Cancer Council, Neutrogena, Bondi Sands, Coles and Woolworths. Ultra Violette's 'skinscreen', which retails for $52, was called out by CHOICE for having the 'most significant failure' in the entire experiment during the watchdog's first round of rigorous testing. 'We were so perturbed by the results that we decided to delay publishing and test a different batch of the Ultra Violette sunscreen at a completely different lab in Germany to confirm the results,' CHOICE experts said. 'Those results came back with a reported SPF of 5.' Just weeks before the bombshell report dropped, Ultra Violette released a slick social media video showcasing the costly process the business says it undertakes to ensure its products meet SPF requirements - singling out how it spent $150,000 on testing. 'Do you know how SPF is actually tested? Making our SKINSCREENS can cost up to $150,000 in testing alone,' the brand said at the time. 'We take the integrity of our products pretty damn seriously - no cutting corners here. We ensure you have the best protection (from both UVA and UVB), and the added skincare benefits to match, no matter where in the world you are.' The video, narrated by Ultra Violette's co-founder Ava Chandler-Matthews, took viewers behind the scenes of how the company tests its sunscreen products - dwelling on how it cost $150,000 to test them. 'Because we formulate our own products at Ultra Violette, we have to pay for all the testing upfront... It's expensive because you do it on real human skin,' Ava said. She explained that the brand undertake the costly process of SPF testing 'multiple times throughout the product development journey'. 'How it works is they apply a test patch of the sunscreen, then they burn you with a UV lamp, with and without the sunscreen,' Ava said. 'The amount of time it takes for your skin to burn is what determines the SPF, but that's the UVB test. The UVA test is done in a lab. We test to Australian standards first because that's always the hardest. After that, we test to FDA standards. 'All of our sunscreens globally are broad spectrum.' Ultra Violette responds to CHOICE At Ultra Violette we take misleading claims made about our products very seriously. Ultra Violette is deeply committed to the health and safety of our customers and only work with reputable, TGA licensed manufacturers who perform substantial quality release testing in accordance with the strictest SPF standards in the world. Given our commitment to producing the highest quality sunscreens for consumers, we do not accept these results as even remotely accurate. Ultra Violette first completed testing for Lean Screen in 2021 (with results of SPF of 64.32 to allow for an SPF 50+ rating), and again in 2024. However, to ensure complete transparency and peace of mind for our customers, we proactively initiated another urgent SPF test of the batch in question in April this year (2025). We retested our product in a full 10-person panel and the results have come back at 61.7, which is above the threshold required by the TGA to make a 50+ claim. Choice's recent retest only included 5 participants, where 2 results were considered non validated, resulting in a sample size of only 3. We rigorously retest our entire SPF range every two years. Lean Screen has been on the market for 5 years in 29 countries and we have not received a single substantiated claim of sunburn during use – reinforcing our confidence in the testing we have. If the Choice results represented the actual level of protection offered, we would have had hundreds of cases of reported sunburn and skin damage while using this product in real life situations. Read the full Ultra Violette statement and the April 2025 test result here. Ava claimed the brand went the extra mile by doing 'additional' testing on all of their sunscreens because, as she said, 'UVA protection is obviously very important to us'. 'The SPF testing is really just the start. When you own all your own formulations, you have to do stability testing which is to make sure the product is stable and contains the UV actives over time as well as clinical and panel testing,' she said. 'Developing all your own formulations, owning your own sunscreen brand and making that sunscreen brand global is really expensive,' she concluded. Following CHOICE's bombshell report, Ultra Violette disputed the claims, saying: 'Given our commitment to producing the highest quality sunscreens for consumers, we do not accept these results as even remotely accurate. 'Lean Screen contains 22.75 per cent zinc oxide, a level at which, when applied sufficiently, would render a testing result of SPF 4 scientifically impossible.' The brand said Lean Screen, like all UV formulas, are made by reputable, TGA-licensed manufacturers and tested to meet the strictest global SPF standards. 'To ensure complete transparency and peace of mind for our customers, when we were first alerted to CHOICE's testing, we immediately initiated another 10 person test on the batch in question at an independent lab,' an Ultra Violette spokesperson said. 'We proactively initiated another urgent SPF test of the batch in question in April this year (2025). We retested our product and the results have come back at 61.7, which is above the threshold required by the TGA to make a 50+ claim. 'CHOICE's recent retest only included five participants, where two results were considered non validated, resulting in a sample size of only three. 'Over the past four years, we have conducted three different tests at independent labs vs. Choice's 1.3 tests.' The surprising results of the 20 popular sunscreens tested Australian consumer watchdog CHOICE has tested 20 popular sunscreens, with 16 failing to meet the SPF50 protection claims on their labels. Of the 20 sunscreens tested, only four passed the SPF test: Cancer Council Kids Sunscreen SPF 50+ passed with a reported SPF of 52 La Roche-Posay Anthelios Wet Skin Sunscreen 50+ passed with a reported SPF of 72 Mecca Cosmetica To Save Body SPF 50+ Hydrating Sunscreen passed with a reported SPF of 51 Neutrogena Ultra Sheer Body Lotion SPF 50 passed with a reported SPF of 56 Sunscreens that failed the SPF test: SPF results in the 10s Ultra Violette Lean Screen SPF 50+ Mattifying Zinc Skinscreen - tested at 4 SPF results in the 20s Aldi Ombra 50+ – tested at 26 Banana Boat Baby Zinc Sunscreen Lotion SPF 50+ – tested at 28 Bondi Sands SPF 50+ Zinc Mineral Body Lotion – tested at 26 Cancer Council Everyday Value Sunscreen 50 – tested at 27 Cancer Council Ultra Sunscreen 50+ – tested at 24 Neutrogena Sheer Zinc Dry-Touch Lotion SPF 50 – tested at 24 Woolworths Sunscreen Everyday Tube SPF 50+ – tested at 27 SPF results in the 30s Banana Boat Sport Sunscreen Lotion SPF 50+ – tested at 35 Bondi Sands SPF 50+ Fragrance Free Sunscreen – tested at 32 Cancer Council Kids Clear Zinc 50+ – tested at 33 Invisible Zinc Face + Body Mineral Sunscreen SPF 50 – tested at 38 SPF results in the 40s Coles SPF 50+ Sunscreen Ultra Tube – tested at 43 Nivea Sun Kids Ultra Protect and Play Sunscreen Lotion SPF 50+ – tested at 41 Nivea Sun Protect and Moisture Lock SPF 50+ Sunscreen – tested at 40 Sun Bum Premium Moisturising Sunscreen Lotion 50+ – tested at 40

Britain morphing into ‘National Health State', says think tank
Britain morphing into ‘National Health State', says think tank

The Independent

time2 hours ago

  • The Independent

Britain morphing into ‘National Health State', says think tank

Britain is turning into a 'National Health State', a think tank has said after the Chancellor gave the NHS a major funding boost in her spending review. The health service was the big winner of Wednesday's spending review, receiving an extra £29 billion per year for day-to-day spending and more cash for capital investment. Overnight, the Resolution Foundation said Rachel Reeves's announcements had followed a recent trend that saw increases for the NHS come at the expense of other public services. Ruth Curtice, chief executive of the Resolution Foundation, said: 'Health accounted for 90% of the extra public service spending, continuing a trend that is seeing the British state morph into a National Health State, with half of public service spending set to be on health by the end of the decade.' Defence was another of Wednesday's winners, Ms Curtice said, receiving a significant increase in capital spending while other departments saw an overall £3.6 billion real-terms cut in investment. The Institute for Fiscal Studies (IFS) made similar arguments about 'substantial' investment in the NHS and defence coming at the expense of other departments, although the think tank's director Paul Johnson warned the money may not be enough. He said: 'Aiming to get back to meeting the NHS 18-week target for hospital waiting times within this Parliament is enormously ambitious – an NHS funding settlement below the long-run average might not measure up. 'And on defence, it's entirely possible that an increase in the Nato spending target will mean that maintaining defence spending at 2.6% of GDP no longer cuts the mustard.' Ms Curtice added that low and middle-income families had also done well out of the spending review 'after two rounds of painful tax rises and welfare cuts', with the poorest fifth of families benefiting from an average of £1,700 in extra spending on schools, hospitals and the police. She warned that, without economic growth, another round of tax rises was likely to come in the autumn as the Chancellor seeks to balance the books. She said: 'The extra money in this spending review has already been accounted for in the last forecast. 'But a weaker economic outlook and the unfunded changes to winter fuel payments mean the Chancellor will likely need to look again at tax rises in the autumn.' Speaking after delivering her spending review, Ms Reeves insisted she would not have to raise taxes to cover her spending review. She told GB News: 'Every penny of this is funded through the tax increases and the changes to the fiscal rules that we set out last autumn.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store